Pontex Polyblend Co.Ltd

8935 · TWO · Basic Materials / Specialty Chemicals

17.15TWD-0.10 (-0.58%)

Price History

Full chart

Market Stats

Previous Close17.25

Open17.35

Day Range16.80 – 17.35

52-Week Range16.50 – 25.00

Volume56.39K

Market Cap2.18B

P/E (TTM)0.00

Forward P/E0.00

EPS-0.57

Dividend Yield0.00%

Beta0.30

50-Day Avg17.88

200-Day Avg19.52

About

Pontex Polyblend Co.,Ltd engages in footwear injection molding and engineering plastics compound materials businesses in Taiwan, the Mainland of China, the United States, and internationally. It offers ABS, PC, nylon, PP, PBT, NPE, TPU, PLA, PBS, and r-PET plastic compound materials for applications in the areas of 3C/electronic products, industrial equipment parts, auto/moto parts, household goods, sports/toy parts, and medical supplies. The company also provides sports equipment, such as baseball, football, soccer, and bicycle outsoles; and shoe components, including midsoles, shanks, and counters, as well as sports shoes. In addition, it manufactures various women vamps injection products on an OEM basis for the CROCS brand. The company was founded in 1982 and is headquartered in Taichung City, Taiwan.

Company Details

SectorBasic Materials
IndustrySpecialty Chemicals
CEOMr. Mao-Ken Shen
Employees215
HeadquartersNo. 23-6, Longxing Lane, Taichung, Taiwan, 42742, Taiwan
Websitehttps://www.pontex.com

Leadership

Mr. Mao-Ken ShenManager
Hsiu-Chu ChungAccounting Officer & Group Finance Manager
Mei-Ling WuVice General Manager

Financials

Income Statement

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31
Total Revenue	969.31M	1.06B	1.38B	946.48M	594.31M	553.24M
Growth (%)	-	+9.37%	+30.10%	-31.37%	-37.21%	-6.91%
Cost of Revenue	830.86M	911.91M	1.17B	774.04M	526.75M	494.68M
Gross Profit	138.45M	148.19M	210.31M	172.44M	67.56M	58.56M
Gross Margin	14.28%	13.98%	15.25%	18.22%	11.37%	10.59%
Operating Expense	117.26M	121.30M	141.01M	127.00M	119.40M	144.34M
Operating Income	21.19M	26.89M	69.30M	45.44M	-51.84M	-85.77M
Operating Margin	2.19%	2.54%	5.02%	4.80%	-8.72%	-15.50%
EBITDA	69.64M	86.30M	125.53M	102.32M	-1.83M	-13.22M
EBITDA Margin	7.18%	8.14%	9.10%	10.81%	-0.31%	-2.39%
Net Income	25.06M	-23.04M	43.46M	27.36M	-69.90M	-73.34M
Net Income Margin	2.59%	-2.17%	3.15%	2.89%	-11.76%	-13.26%
R&D	8.35M	11.56M	21.27M	17.90M	11.73M	22.78M
R&D as % of Total Revenue	0.86%	1.09%	1.54%	1.89%	1.97%	4.12%
Interest Expense	14.80M	21.49M	18.24M	19.25M	20.38M	14.12M
Interest Expense % of Total Revenue	1.53%	2.03%	1.32%	2.03%	3.43%	2.55%

Balance Sheet

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31
Total Assets	1.72B	1.81B	1.77B	1.72B	1.55B	1.50B
Total Liabilities	918.26M	1.04B	984.07M	883.17M	679.78M	537.23M
Total Equity	802.75M	771.85M	783.67M	837.87M	865.75M	967.49M
Cash	99.21M	100.67M	112.15M	151.39M	107.76M	114.44M
Total Debt	769.21M	854.10M	857.96M	787.88M	587.88M	-
Net Debt	670.00M	753.43M	745.82M	636.48M	480.12M	350.39M

Cash Flow

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31
Operating Cash Flow	-47.41M	45.32M	39.30M	146.99M	79.51M	-4.01M
Financing Cash Flow	-1.97M	82.42M	-4.56M	-75.89M	-77.78M	-
Capital Expenditure	239.00M	62.47M	18.89M	11.97M	20.93M	28.27M
Free Cash Flow	-286.42M	-17.15M	20.41M	135.02M	58.58M	-32.29M
FCF to OCF	604.09%	-37.84%	51.93%	91.86%	73.68%	804.33%

Key Statistics & Ratios

Market Cap2.18B

Enterprise Value2.20B

Trailing P/E0.00

Forward P/E0.00

Price / Sales4.42

Price / Book2.27

EPS-0.57

Book Value7.64

Revenue (TTM)492.64M

Gross Profit (TTM)63.05M

EBITDA-22.55M

Profit Margin-13.19%

Operating Margin-10.09%

Return on Equity-7.53%

Return on Assets-2.88%

Shares Outstanding113.50M

Shares Float68.11M

Beta0.30

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Oct 12, 20231026.4911:1000
Oct 22, 20130.5959:1
Oct 8, 20090.6788:1
Jul 17, 2008105:100